582 Companies
Vaccinex Inc. is a clinical-stage immunotherapy company focused on developing targeted biotherapeutics to treat unmet medical needs, including cancer and neurodegenerative diseases. The company is ...
Vaccinex, Inc. Annual Report 2023Intellia Therapeutics, Inc., a genome editing company, is taking a targeted approach to the development of curative therapeutics. The company's in vivo programs are focused on a variety of potentia...
Intellia Therapeutics Annual Report 2023DiaMedica Therapeutics Inc., a biopharmaceutical company operating in the clinical stage, is making significant strides in the development of treatments for neurological and kidney diseases. Its gr...
DiaMedica Therapeutics Inc. Annual Report 2023In an effort to combat cancer, Merus N.V. - a clinical-stage immuno-oncology company based in the Netherlands - is developing a pipeline of promising antibody therapeutics. Among its candidates is ...
Merus Annual Report 2023VistaGen Therapeutics Inc., a clinical-stage firm that specializes in biopharmaceutical products, is currently focused on developing and commercializing a range of drugs that aim to address anxiety...
VistaGen Therapeutics Inc Annual Report 2023Austin-based Genprex, Inc., a clinical-stage gene therapy company specializing in cancer and diabetes treatments, is making strides with its lead product candidate REQORSA (GPX-001). REQORSA has sh...
Genprex, Inc. Annual Report 2023Bicycle Therapeutics plc, a clinical-stage biopharmaceutical firm, is working on developing a new class of medications to treat ailments that are currently underserved by existing treatments. The f...
Bicycle Therapeutics plc Annual Report 2023The Eaton Vance Municipal Income 2028 Term Trust, a fixed income mutual fund, has been launched and managed by Eaton Vance Management in the United States. Operating as a closed ended fund, the tru...
Etrion Corporation Annual Report 2023Clinical-stage pharmaceutical company Plus Therapeutics, Inc. is dedicated to developing, manufacturing, and commercializing cancer and disease treatments. The company's primary focus is on Rhenium...
Plus Therapeutics Annual Report 2023Gemphire is a clinical-stage biopharmaceutical company that is dedicated to finding new ways to treat patients suffering from cardiometabolic disorders. Their main focus is on developing a product ...
Gemphire Therapeutics Inc Annual Report 2019Pharmaceutical company Esperion Therapeutics, Inc. is dedicated to developing and commercializing innovative treatments for patients with elevated low density lipoprotein cholesterol. Its two lead ...
Esperion Therapeutics Annual Report 2023Acorda Therapeutics, a biopharmaceutical company dedicated to combating neurological disorders, has made significant strides over its 26-year history. One of its most notable achievements is the de...
Acorda Therapeutics Annual Report 2023Millendo Therapeutics is a clinical-stage biopharmaceutical company specializing in the development of new treatments for endocrine diseases with significant unmet medical needs. The company's prim...
Millendo Therapeutics, Inc. Annual Report 2019Phio Pharmaceuticals Corp, a US-based biotech firm, is making significant strides in the development of immuno-oncology therapeutics. The company's portfolio includes PH-762, which activates immune...
Phio Pharmaceuticals Corp. Annual Report 2023Xeris Biopharma Holdings, Inc. is a cutting-edge biopharmaceutical company operating out of Illinois. The company has made a name for itself by creating, developing, and selling innovative therapie...
Xeris Biopharma Holdings Inc Annual Report 2023